What did @tianataurima actually say?
Short version: she's announcing a new peptide protocol aimed at physical transformation, specifically "looks maxing," and she's starting on what she calls "redder" (almost certainly retatrutide, a GLP-1/GIP/glucagon triple agonist) and "MT2" (melanotan II, a synthetic melanocortin peptide). Her claim is simple but loaded: "knew me unlocked both." That's a transformation promise, not a medical disclosure.
There's no dosing information, no mention of medical supervision, and no discussion of side effects. It's framed as a lifestyle upgrade, which is exactly the kind of framing that makes regulatory bodies nervous about peptide content on social media. The enthusiasm is real. The context is almost entirely absent.
Does the science back this up?
For retatrutide, yes, there's legitimate Phase 2 data. For melanotan II, the evidence picture is considerably messier, and the risk profile is not something you'd casually announce over TikTok.
Retatrutide (LY3437943) showed statistically significant weight reduction in a Phase 2 trial published by Jastreboff et al. (2023, New England Journal of Medicine), with participants losing up to 24.2% body weight over 48 weeks. It acts on GLP-1, GIP, and glucagon receptors simultaneously, which is a more aggressive mechanism than semaglutide alone. That's real data from a real trial.
Melanotan II is a different story. It's a synthetic analogue of alpha-melanocyte-stimulating hormone that stimulates melanin production and has documented effects on sexual arousal and appetite suppression. However, it has never completed a successful regulatory approval pathway. Studies like those reviewed by Rosen et al. (2014, Journal of Sexual Medicine) note significant adverse effects including nausea, spontaneous erections, facial flushing, and potential cardiovascular concerns. The tanning effects are real but so are the unknowns around long-term melanocytic activity.
What did they get wrong (or right)?
She didn't get facts wrong because she didn't really state any. That's actually the problem. "Knew me unlocked" is a vibe, not a claim. But the implicit promise, that these two compounds together will produce dramatic aesthetic results, deserves scrutiny.
Retatrutide is still investigational. It is not FDA-approved as of early 2025. Compounded versions circulating in peptide markets have not gone through the same manufacturing controls as clinical trial material. That gap matters.
Melanotan II is not approved anywhere for cosmetic or therapeutic use. The FDA issued warnings about it specifically. Using it for "looks maxing" without disclosing that it's an unregulated, unapproved compound with a documented side effect profile is a meaningful omission, even in a hype video. She deserves credit for being upfront that she's starting a new protocol. She does not get credit for making it sound like a skincare haul.
What should you actually know?
If you're curious about retatrutide because of this video, here's the honest framing: it's one of the more promising compounds in the GLP-1 class based on early trial data, but it is not available as an approved drug. What's sold as retatrutide in peptide markets is compounded or research-grade material with no guarantee of purity, potency, or sterility. That is not a technicality. Contaminated peptide vials have caused real harm.
Melanotan II carries a different risk profile. Beyond nausea and flushing, there are case reports linking MT-2 use to changes in existing moles and atypical melanocytic lesions, reviewed by Langan et al. (2020, Clinical and Experimental Dermatology). Using a compound that artificially stimulates melanocortin receptors without dermatological monitoring is not a reasonable DIY protocol.
- Retatrutide has Phase 2 efficacy data but is not approved for clinical use outside trials.
- Melanotan II has no approved therapeutic indication anywhere and carries documented dermatological risks.
- Neither compound should be sourced or used without verified medical oversight.
The bottom line on this video
The video is promotional framing dressed as a personal journey. That's fine as content. It's not fine as health information. The compounds she's named have real pharmacological effects, which means they also have real risks that a hype reel doesn't cover. Anyone watching this and thinking about following her protocol should understand they'd be using unapproved, unregulated compounds based on a TikTok announcement with no clinical context attached to it.
Formblends will update this analysis as retatrutide moves through its regulatory pathway and as more post-market data on compounded melanocortin peptides becomes available.